跳至主要内容
临床试验/NL-OMON31426
NL-OMON31426尚未招募不适用

Individuals at high-risk for developing pancreatic cancer: surveillance by endosonography and magnetic resonance imaging: FAMILIAL PANCREATIC CANCER SURVEILLANCE STUDY - FAMILIAL PANCREATIC CANCER SURVEILLANCE STUDY

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • PC prone hereditary syndromes with a cumulative lifetime risk >10% on PC, or
  • PC prone hereditary syndromes with a unknown cumulative lifetime risk, or <10% for PC, with a familial aggregation of PC (* 2 first-degree relatives with a histologically confirmed PC, or * 3 relatives of any degree with a histologically confirmed PC, one of whom must have been a first-degree relative, or * 2 relatives of any degree, one of whom was at least * 50 years at the time of diagnosis, with a histologically confirmed PC), or
  • Familial pancreatic cancer (* 2 first-degree relatives with a histologically confirmed PC, or * 3 relatives of any degree with a histologically confirmed PC, one of whom must have been a first-degree relative, or * 2 relatives of any degree, one of whom was at least * 50 years at the time of diagnosis, with a histologically confirmed PC), apparently unrelated to any currently recognized hereditary syndrome

排除标准

  • Clinical evidence of PC and / or PC in the medical history,
  • Medical comorbidities or coagulopathy that contraindicate endoscopy,
  • Medical comorbidities or coagulopathy that contraindicate pancreatic surgery,
  • Karnofsky performance score < 60

研究者

相似试验